Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
29696 | 181 | 32.6 | 75% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
33 | 3 | JOURNAL OF BACTERIOLOGY//MICROBIOLOGY//MOLECULAR MICROBIOLOGY | 107033 |
2025 | 2 | FTSZ//PEPTIDOGLYCAN//BACTERIAL CELL DIVISION | 5424 |
29696 | 1 | LRMA//EQUIPE 12//L D TRANSPEPTIDASE | 181 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LRMA | address | 1043924 | 14% | 25% | 25 |
2 | EQUIPE 12 | address | 771196 | 9% | 29% | 16 |
3 | L D TRANSPEPTIDASE | authKW | 759166 | 3% | 75% | 6 |
4 | USM0502 | address | 719797 | 4% | 53% | 8 |
5 | UMR8041 | address | 552117 | 3% | 55% | 6 |
6 | RECH DEV ERS MOL | address | 539852 | 2% | 80% | 4 |
7 | PLATEFORME SPE OMETRIE MASSE PROTE MUSEUM | address | 527197 | 3% | 63% | 5 |
8 | LRMAUMR S 872 | address | 506113 | 2% | 100% | 3 |
9 | PLATEFORME SPE OMETRIE MASSE PROTEOM MUSEUM | address | 506113 | 2% | 100% | 3 |
10 | ANTITUBERCULOSIS DRUG DISCOVERY | authKW | 337408 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Microbiology | 2412 | 48% | 0% | 87 |
2 | Pharmacology & Pharmacy | 382 | 28% | 0% | 51 |
3 | Infectious Diseases | 273 | 12% | 0% | 22 |
4 | Biochemistry & Molecular Biology | 160 | 28% | 0% | 50 |
5 | Chemistry, Medicinal | 103 | 8% | 0% | 14 |
6 | Biophysics | 62 | 8% | 0% | 14 |
7 | Respiratory System | 39 | 4% | 0% | 8 |
8 | Crystallography | 11 | 3% | 0% | 5 |
9 | Immunology | 7 | 5% | 0% | 9 |
10 | Medicine, Research & Experimental | 6 | 3% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LRMA | 1043924 | 14% | 25% | 25 |
2 | EQUIPE 12 | 771196 | 9% | 29% | 16 |
3 | USM0502 | 719797 | 4% | 53% | 8 |
4 | UMR8041 | 552117 | 3% | 55% | 6 |
5 | RECH DEV ERS MOL | 539852 | 2% | 80% | 4 |
6 | PLATEFORME SPE OMETRIE MASSE PROTE MUSEUM | 527197 | 3% | 63% | 5 |
7 | LRMAUMR S 872 | 506113 | 2% | 100% | 3 |
8 | PLATEFORME SPE OMETRIE MASSE PROTEOM MUSEUM | 506113 | 2% | 100% | 3 |
9 | EQUIPE GOBS | 337408 | 1% | 100% | 2 |
10 | TASKFORCE STUDY ISTANCE EMERGENCE ANTIMICROB | 303665 | 2% | 60% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 6870 | 17% | 0% | 31 |
2 | MICROBIOS | 2708 | 3% | 0% | 5 |
3 | TUBERCLE AND LUNG DISEASE | 1512 | 1% | 0% | 2 |
4 | ACS INFECTIOUS DISEASES | 1008 | 1% | 1% | 1 |
5 | BIOMOLECULAR NMR ASSIGNMENTS | 963 | 1% | 0% | 2 |
6 | STRUCTURE | 705 | 2% | 0% | 4 |
7 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 653 | 4% | 0% | 7 |
8 | HIROSHIMA JOURNAL OF MEDICAL SCIENCES | 522 | 1% | 0% | 1 |
9 | WILEY INTERDISCIPLINARY REVIEWS-RNA | 458 | 1% | 0% | 1 |
10 | JOURNAL OF BACTERIOLOGY | 400 | 5% | 0% | 9 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | L D TRANSPEPTIDASE | 759166 | 3% | 75% | 6 | Search L+D+TRANSPEPTIDASE | Search L+D+TRANSPEPTIDASE |
2 | ANTITUBERCULOSIS DRUG DISCOVERY | 337408 | 1% | 100% | 2 | Search ANTITUBERCULOSIS+DRUG+DISCOVERY | Search ANTITUBERCULOSIS+DRUG+DISCOVERY |
3 | PEPTIDYL RNA CONJUGATES | 337408 | 1% | 100% | 2 | Search PEPTIDYL+RNA+CONJUGATES | Search PEPTIDYL+RNA+CONJUGATES |
4 | AMPICILLIN CLAVULANATE | 168704 | 1% | 100% | 1 | Search AMPICILLIN+CLAVULANATE | Search AMPICILLIN+CLAVULANATE |
5 | BIAC | 168704 | 1% | 100% | 1 | Search BIAC | Search BIAC |
6 | CARBAPENEMS PLUS CLAVULANATE | 168704 | 1% | 100% | 1 | Search CARBAPENEMS+PLUS+CLAVULANATE | Search CARBAPENEMS+PLUS+CLAVULANATE |
7 | CAS 58001 44 8 | 168704 | 1% | 100% | 1 | Search CAS+58001+44+8 | Search CAS+58001+44+8 |
8 | CEFEPIMER | 168704 | 1% | 100% | 1 | Search CEFEPIMER | Search CEFEPIMER |
9 | CRP REGULATED GENES | 168704 | 1% | 100% | 1 | Search CRP+REGULATED+GENES | Search CRP+REGULATED+GENES |
10 | CYCLODIPEPTIDES SYNTHASES | 168704 | 1% | 100% | 1 | Search CYCLODIPEPTIDES+SYNTHASES | Search CYCLODIPEPTIDES+SYNTHASES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TRIBOULET, S , BOUGAULT, CM , LAGURI, C , HUGONNET, JE , ARTHUR, M , SIMORRE, JP , (2015) ACYL ACCEPTOR RECOGNITION BY ENTEROCOCCUS FAECIUM L,D-TRANSPEPTIDASE LDT(FM).MOLECULAR MICROBIOLOGY. VOL. 98. ISSUE 1. P. 90 -100 | 24 | 80% | 1 |
2 | DUBEE, V , TRIBOULET, S , MAINARDI, JL , ETHEVE-QUELQUEJEU, M , GUTMANN, L , MARIE, A , DUBOST, L , HUGONNET, JE , ARTHUR, M , (2012) INACTIVATION OF MYCOBACTERIUM TUBERCULOSIS L,D-TRANSPEPTIDASE LDT(MT1) BY CARBAPENEMS AND CEPHALOSPORINS.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 56. ISSUE 8. P. 4189-4195 | 22 | 79% | 27 |
3 | FORSMAN, LD , GISKE, CG , BRUCHFELD, J , SCHON, T , JUREEN, P , ANGEBY, K , (2015) MEROPENEM-CLAVULANIC ACID HAS HIGH IN VITRO ACTIVITY AGAINST MULTIDRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 59. ISSUE 6. P. 3630 -3632 | 21 | 72% | 3 |
4 | TRIBOULET, S , DUBEE, V , LECOQ, L , BOUGAULT, C , MAINARDI, JL , RICE, LB , ETHEVE-QUELQUEJEU, M , GUTMANN, L , MARIE, A , DUBOST, L , ET AL (2013) KINETIC FEATURES OF L,D-TRANSPEPTIDASE INACTIVATION CRITICAL FOR BETA-LACTAM ANTIBACTERIAL ACTIVITY.PLOS ONE. VOL. 8. ISSUE 7. P. - | 18 | 90% | 4 |
5 | IANNAZZO, L , SOROKA, D , TRIBOULET, S , FONVIELLE, M , COMPAIN, F , DUBEE, V , MAINARDI, JL , HUGONNET, JE , BRAUD, E , ARTHUR, M , ET AL (2016) ROUTES OF SYNTHESIS OF CARBAPENEMS FOR OPTIMIZING BOTH THE INACTIVATION OF L,D-TRANSPEPTIDASE LDT(MT1) OF MYCOBACTERIUM TUBERCULOSIS AND THE STABILITY TOWARD HYDROLYSIS BY BETA-LACTAMASE BLAC.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 59. ISSUE 7. P. 3427 -3438 | 23 | 62% | 1 |
6 | KUMAR, P , KAUSHIK, A , LLOYD, EP , LI, SG , MATTOO, R , AMMERMAN, NC , BELL, DT , PERRYMAN, AL , ZANDI, TA , EKINS, S , ET AL (2017) NON-CLASSICAL TRANSPEPTIDASES YIELD INSIGHT INTO NEW ANTIBACTERIALS.NATURE CHEMICAL BIOLOGY. VOL. 13. ISSUE 1. P. 54 -61 | 19 | 76% | 0 |
7 | CORDILLOT, M , DUBEE, V , TRIBOULET, S , DUBOST, L , MARIE, A , HUGONNET, JE , ARTHUR, M , MAINARDI, JL , (2013) IN VITRO CROSS-LINKING OF MYCOBACTERIUM TUBERCULOSIS PEPTIDOGLYCAN BY L,D-TRANSPEPTIDASES AND INACTIVATION OF THESE ENZYMES BY CARBAPENEMS.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 57. ISSUE 12. P. 5940-5945 | 18 | 75% | 27 |
8 | JAGANATH, D , LAMICHHANE, G , SHAHS, M , (2016) CARBAPENEMS AGAINST MYCOBACTERIUM TUBERCULOSIS: A REVIEW OF THE EVIDENCE.INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. VOL. 20. ISSUE 11. P. 1436 -1447 | 24 | 60% | 0 |
9 | BASTA, LAB , GHOSH, A , PAN, Y , JAKONCIC, J , LLOYD, EP , TOWNSEND, CA , LAMICHHANE, G , BIANCHET, MA , (2015) LOSS OF A FUNCTIONALLY AND STRUCTURALLY DISTINCT LD-TRANSPEPTIDASE, LDT(MT5), COMPROMISES CELL WALL INTEGRITY IN MYCOBACTERIUM TUBERCULOSIS.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 290. ISSUE 42. P. 25670 -25685 | 25 | 56% | 2 |
10 | SCHOONMAKER, MK , BISHAI, WR , LAMICHHANE, G , (2014) NONCLASSICAL TRANSPEPTIDASES OF MYCOBACTERIUM TUBERCULOSIS ALTER CELL SIZE, MORPHOLOGY, THE CYTOSOLIC MATRIX, PROTEIN LOCALIZATION, VIRULENCE, AND RESISTANCE TO BETA-LACTAMS.JOURNAL OF BACTERIOLOGY. VOL. 196. ISSUE 7. P. 1394 -1402 | 20 | 51% | 16 |
Classes with closest relation at Level 1 |